OCGN Summary

  1. NASDAQ
  2. >
  3. OCGN
TickerOCGN
DescriptionOCUGEN INC
Ocugen, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19. Its breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with one drug - "one to many" and its novel biologic product candidate aims to offer better therapy to patients with underserved diseases such as wet age-related macular degeneration, diabetic macular edema, and diabetic retinopathy. The Company is co-developing Bharat Biotech's COVAXIN™ vaccine candidate for COVID-19 in the U.S. market.
ExchangeNASDAQ
TypeStock
SectorHealthcare
Next Earnings DateAugust 13th, 2021
IV99.066323%
IV Percentile0
IV Rank0.00%
IV Skew4.720431
IV Skew Percentile85th
IV Skew SentimentBearish
Option Volume21,098
Volume8,754,882
Price$6.9609
Previous Close$7.08
52-Week High$18.77
52-Week Low$0.2501
50-Day Moving Avg.$7.50
200-Day Moving Avg.$7.55
10-Day Avg. Volume20,565,430
20-Day Avg. Volume22,415,621
30-Day Avg. Volume23,828,151
3-Month Avg. Volume62,395,313
EPS-$0.28
Outstanding Shares198,228,533
Market Capitalization$1,526,359,700
CurrencyUSD
UpdatedJuly 23rd, 2021